Mountain View, CA — Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc. and provider of innovative reagents and kits for the life sciences, announced today that it has earned ISO 13485:2003 certification, an internationally-recognized quality standard for medical devices and related services. This certification confirms that Clontech has successfully implemented a quality management […]
FREMONT, Calif. and LUXEMBOURG — WaferGen Bio-systems (NASDAQ: WGBS) announced today that the Company has signed a collaboration agreement with the Luxembourg Institute of Health (LIH), a leading public medical research center that specializes in oncology, infectious diseases, immunology, and population health. LIH will provide laboratory facilities for the ICELL8™ Single-Cell System and use of […]
San Antonio, Texas — Local organizations BioBridge Global (BBG) and StemBioSys Inc. (SBS), a privately held development-stage biomedical company in the emerging field of stem cells and regenerative medicine are expanding their research collaboration with the goal of bringing a new source of stem cells to the research market. The deal will leverage the unique […]
FREMONT, Calif. — WaferGen Bio-systems, Inc. (Nasdaq:WGBS) today announced the first commercial sale of WaferGen’s ICELL8™ Single-Cell System to a major global pharmaceutical company. The system will enable greater single-cell throughput, and provide key insights to be used in important cancer-related research initiatives. “The first commercial sale of our ICELL8 Single-Cell System is a significant […]
Mannheim, Germany. Leica Microsystems launches the HyVolution true confocal super-resolution technology for the Leica TCS SP8 confocal microscope platform, extending its imaging portfolio in the sub-diffraction regime. HyVolution allows researchers to achieve everything at the same time: They can resolve structures down to 140 nm with multiple colors, with high imaging speed, and high signal-to-noise […]
BUFFALO, N.Y. — Albany Molecular Research Inc. (NASDAQ: AMRI) today introduces its new U.S.-based integrated drug discovery center in Buffalo, N.Y. Located on the Buffalo Niagara Medical Campus and part of the larger commitment by the State of New York with SUNY Polytechnic Institute, this drug discovery center offers customers leading-edge platforms and capabilities for […]
Schlieren, Switzerland – InSphero AG, the leading supplier of easy-to-use solutions for production, culture, and assessment of more organotypic 3D cell culture models, has promoted Melanie Aregger to serve as Chief Operating Officer. Having joined InSphero in November 2013 as Business Development Manager, Ms. Aregger served on the management team and was promoted to Head […]
Cambridge, UK: Horizon Discovery Group plc (LSE:HZD) (Horizon), the international life science company supplying research tools and services to organizations engaged in genomics research and the development of personalized medicines, and Axol Bioscience Ltd (Axol), a biotechnology company specializing in the use of stem cell technology to manufacture disease relevant cell based assay systems, announce […]
NEW YORK – Germany’s Merck KGaA today announced the completion of its $17 billion acquisition of Sigma-Aldrich, following approval from the European Commission. The deal creates a science sector giant that will “cover every step of the biotech production chain,” Merck said in a statement. The company will have around 50,000 employees in 67 countries, […]
ALAMEDA, Calif. — BioTime, Inc. (NYSE MKT and TASE: BTX), a clinical-stage regenerative medicine company with a focus on pluripotent stem cell technology, today announced that the Company’s Board of Directors has appointed Russell Skibsted to the position of Chief Financial Officer, succeeding Robert Peabody. Mr. Russell Skibsted brings over 25 years of financial management […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
